Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.13 USD | +1.75% | +3.17% | +151.70% |
10:29am | Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket | MT |
May. 14 | Arcutis Biotherapeutics Q1 Loss Narrows, Revenue Increases; Shares Jump | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+151.70% | 939M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.35% | 21.25B | |
-6.08% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Needham Raises Price Target on Arcutis Biotherapeutics to $16 From $8, Maintains Buy Rating